Today, the DREAMS Partnership took a stand toward rewriting this tragic but far too common story by issuing a call for innovative ideas as part of the DREAMS Innovation Challenge. The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), Janssen Pharmaceutica NV (one of the Janssen pharmaceutical companies of Johnson & Johnson), and ViiV Healthcare committed $85 million for the Challenge to award solutions that infuse new thinking and approaches to give young women the opportunity to live Determined, Resilient, Empowered, AIDS-Free, Mentored, and Safe lives.

Read More at Huffington Post

Subscribe for IdeaScale News

Enter your email address to subscribe and receive notifications of new posts by email

Today, the DREAMS Partnership took a stand toward rewriting this tragic but far too common story by issuing a call for innovative ideas as part of the DREAMS Innovation Challenge. The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), Janssen Pharmaceutica NV (one of the Janssen pharmaceutical companies of Johnson & Johnson), and ViiV Healthcare committed $85 million for the Challenge to award solutions that infuse new thinking and approaches to give young women the opportunity to live Determined, Resilient, Empowered, AIDS-Free, Mentored, and Safe lives.

Read More at Huffington Post

Subscribe for IdeaScale News

Enter your email address to subscribe and receive notifications of new posts by email

Today, the DREAMS Partnership took a stand toward rewriting this tragic but far too common story by issuing a call for innovative ideas as part of the DREAMS Innovation Challenge. The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), Janssen Pharmaceutica NV (one of the Janssen pharmaceutical companies of Johnson & Johnson), and ViiV Healthcare committed $85 million for the Challenge to award solutions that infuse new thinking and approaches to give young women the opportunity to live Determined, Resilient, Empowered, AIDS-Free, Mentored, and Safe lives.

Read More at Huffington Post

Subscribe for IdeaScale News

Enter your email address to subscribe and receive notifications of new posts by email